ULTRALIFE CORP Quarterly Cost of Revenue in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Ultralife Corp quarterly/annual Cost of Revenue history and growth rate from Q1 2015 to Q3 2024.
  • Ultralife Corp Cost of Revenue for the quarter ending September 30, 2024 was $27M, a 9.09% decline year-over-year.
  • Ultralife Corp Cost of Revenue for the twelve months ending September 30, 2024 was $122M, a 6.75% increase year-over-year.
  • Ultralife Corp annual Cost of Revenue for 2023 was $119M, a 16.6% increase from 2022.
  • Ultralife Corp annual Cost of Revenue for 2022 was $102M, a 39.1% increase from 2021.
  • Ultralife Corp annual Cost of Revenue for 2021 was $73.6M, a 6.27% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $122M $27M -$2.7M -9.09% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $125M $31.4M -$684K -2.13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $125M $30.5M +$5.98M +24.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $119M $33.1M +$5.12M +18.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $114M $29.7M +$3.2M +12% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $111M $32.1M +$7.62M +31.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $104M $24.5M +$1.07M +4.55% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $102M $28M +$9.55M +51.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $92.9M $26.5M +$9.87M +59.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $83M $24.5M +$4.98M +25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $78M $23.4M +$4.42M +23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $73.6M $18.5M -$3.15M -14.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $76.8M $16.7M -$1.2M -6.71% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $78M $19.5M -$1.09M -5.31% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $79.1M $19M +$515K +2.79% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $78.6M $21.6M -$43K -0.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 $78.6M $17.9M -$1.78M -9.07% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $80.4M $20.6M +$65K +0.32% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $80.3M $18.5M +$4.68M +33.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $75.6M $21.7M +$6.45M +42.4% Sep 30, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 $69.2M $19.6M +$5.34M +37.4% Jul 1, 2019 Sep 29, 2019 10-Q 2020-10-29
Q2 2019 $63.8M $20.5M +$4.22M +25.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $59.6M $13.8M -$1.99M -12.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $61.6M $15.2M -$427K -2.73% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-06
Q3 2018 $62M $14.3M -$503K -3.4% Jul 2, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $62.5M $16.3M +$2.6M +18.9% Apr 1, 2018 Jul 1, 2018 10-Q 2019-08-01
Q1 2018 $59.9M $15.8M +$642K +4.24% Jan 1, 2018 Apr 1, 2018 10-Q 2019-05-02
Q4 2017 $59.3M $15.6M +$825K +5.57% Oct 2, 2017 Dec 31, 2017 10-K/A 2019-02-15
Q3 2017 $58.5M $14.8M +$1.16M +8.49% Jul 3, 2017 Oct 1, 2017 10-Q 2018-11-01
Q2 2017 $57.3M $13.7M -$753K -5.2% Apr 3, 2017 Jul 2, 2017 10-Q 2018-08-02
Q1 2017 $58.1M $15.1M +$717K +4.97% Jan 1, 2017 Apr 2, 2017 10-Q 2018-05-03
Q4 2016 $57.4M $14.8M +$1.12M +8.16% Sep 26, 2016 Dec 31, 2016 10-K 2018-02-08
Q3 2016 $56.2M $13.6M +$490K +3.73% Jun 27, 2016 Sep 25, 2016 10-Q 2017-11-02
Q2 2016 $55.7M $14.5M +$1.38M +10.5% Mar 28, 2016 Jun 26, 2016 10-Q 2017-08-03
Q1 2016 $54.4M $14.4M +$1.26M +9.55% Jan 1, 2016 Mar 27, 2016 10-Q 2017-05-04
Q4 2015 $53.1M $13.7M Sep 28, 2015 Dec 31, 2015 10-K 2017-02-09
Q3 2015 $13.1M Jun 29, 2015 Sep 27, 2015 10-Q 2016-10-27
Q2 2015 $13.1M Mar 30, 2015 Jun 28, 2015 10-Q 2016-07-28
Q1 2015 $13.2M Dec 29, 2014 Mar 29, 2015 10-Q 2016-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.